Anticoagulation Maintenance
Cross-source consensus on Anticoagulation Maintenance from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Benefits
Dosage & preparation
Highlighted claims
- Patients assigned to maintenance continue anticoagulation with handling that differs by drug class. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- Vitamin K antagonist users in the maintenance arm continue medication if INR is therapeutic and below 3.5 within 24 hours before the procedure. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- Direct oral anticoagulant users in the maintenance arm omit only the morning dose on colonoscopy day. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- The protocol treats same-day morning-dose omission for direct oral anticoagulants as pharmacological continuation because therapeutic levels persist. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- Maintaining anticoagulation may reduce unnecessary suspension for patients who have no intervention during colonoscopy. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM